NTLA Intellia Therapeutics

Healthcare Gene Editing

Latest news and analysis for Intellia Therapeutics (NTLA).

1 article | Category: Healthcare

Current Price

$13.78 -0.50 (-3.50%)

Market data may be delayed

Price Chart

Loading chart...

All Articles for NTLA

Healthcare | NTLA | 1w ago

NTLA Climbs After H.C. Wainwright Boosts Price Target to $25

Intellia Therapeutics (NTLA) sees a surge in analyst confidence as H.C. Wainwright raises its price target to $25, spurring investor interest.

Related Stocks in Healthcare

Eli Lilly 6 articles

Pfizer Inc. 3 articles

Vertex Pharmaceuticals 3 articles

Ultragenyx Pharmaceutical 3 articles

Novo Nordisk 3 articles

Hims & Hers Health 3 articles

Johnson & Johnson 2 articles

Gilead Sciences 2 articles

Stryker Corp. 2 articles

Regeneron Pharmaceuticals 2 articles

Elevance Health 2 articles

Humana Inc. 2 articles